{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:22:47Z","timestamp":1793330567576,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1097\/mph.0b013e3182431e02","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T21:29:31Z","timestamp":1371158971000},"page":"271-275","source":"Crossref","is-referenced-by-count":27,"title":["Plasma Cytokine Profiles at Diagnosis in Pediatric Patients With Non-Hodgkin Lymphoma"],"prefix":"10.1097","volume":"34","author":[{"given":"Karin","family":"Mellgren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris Juul","family":"Hedegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjeld","family":"Schmiegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/pr100729z","article-title":"Assessment of prediagnosis biomarkers of immune activation and inflammation: insight on the etiology of lymphoma.","volume":"10","author":"Verdame","year":"2011","journal-title":"J Proteome Res"},{"key":"R2-6-20210227","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"454","author":"Manovani","year":"2008","journal-title":"Nature"},{"key":"R3-6-20210227","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"R4-6-20210227","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/01.cco.0000239882.23839.e5","article-title":"Pathogenesis of AIDS lymphoma: role of oncogenic viruses and B-cell activation-associated molecular lesions.","volume":"18","author":"Epeldegui","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"R5-6-20210227","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood-2009-04-217521","article-title":"A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.","volume":"114","author":"Purdue","year":"2009","journal-title":"Blood"},{"key":"R6-6-20210227","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10552-010-9560-3","article-title":"Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study.","volume":"21","author":"Gu","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R7-6-20210227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwp383","article-title":"Tumor necrosis factor (TNF) and lymphotoxin- (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.","volume":"171","author":"Skibola","year":"2010","journal-title":"Am J Epidemiol"},{"key":"R8-6-20210227","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1055-9965.EPI-09-1237","article-title":"Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European prospective investigation into cancer and nutrition.","volume":"19","author":"Saberi Hosnijeh","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R9-6-20210227","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-0609.1995.tb01619.x","article-title":"Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkins lymphoma.","volume":"54","author":"Stasi","year":"1995","journal-title":"Eur J Haematol"},{"key":"R10-6-20210227","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(05)70434-4","article-title":"Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.","volume":"7","author":"Rothman","year":"2006","journal-title":"Lancet Oncol"},{"key":"R11-6-20210227","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2796.2008.02032.x","article-title":"Inflammatory cells and immune microenvironment in malignant lymphoma.","volume":"264","author":"De Jong","year":"2008","journal-title":"J Intern Med"},{"key":"R14-6-20210227","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95.","volume":"105","author":"Woessmann","year":"2005","journal-title":"Blood"},{"key":"R15-6-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.mph.0000139772.98685.d2","article-title":"Nordic Society of Pediatric Hematology and Oncology. Intensive chemotherapy without radiotherapy gives more than 85 event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the Nordic Society of Pediatric Hematology and Oncology.","volume":"26","author":"Marky","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"R16-6-20210227","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","article-title":"Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90.","volume":"97","author":"Seidemann","year":"2001","journal-title":"Blood"},{"key":"R17-6-20210227","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1200\/JCO.2008.18.1487","article-title":"Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.","volume":"27","author":"Brugieres","year":"2009","journal-title":"J Clin Oncol"},{"key":"R18-6-20210227","first-page":"741","article-title":"Cure of X-linked lymphoproliferative disease (XLP) with allogenic hematopoietic stem cell transplantation. Report from the XLP registry.","volume":"17","author":"Gross","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R19-6-20210227","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.intimp.2004.09.022","article-title":"Plasma TNF binding capacity in patients with juvenile idiopathic arthritis.","volume":"5","author":"Bjornhart","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"R20-6-20210227","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1615\/CritRevOncog.v5.i5.30","article-title":"Hodgkins disease: a cytokine producing tumour: a review.","volume":"5","author":"Gross","year":"1994","journal-title":"Crit Rev Oncol"},{"key":"R22-6-20210227","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2009-12-257030","article-title":"EGR-1 activation by EGF inhibits MMP-9 expression and lymphoma growth.","volume":"116","author":"Bouchard","year":"2010","journal-title":"Blood"},{"key":"R23-6-20210227","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2183\/pjab.86.588","article-title":"Review: the discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine.","volume":"86","author":"Nakamura","year":"2010","journal-title":"Proc Jpn Acad Ser B"},{"key":"R24-6-20210227","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrm3012","article-title":"Met signaling: principles and functions in development, organ regeneration and cancer.","volume":"11","author":"Trusolono","year":"2010","journal-title":"Nat Rev"},{"key":"R25-6-20210227","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ijc.21808","article-title":"Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions.","volume":"119","author":"Matsumoto","year":"2006","journal-title":"Int J Cancer"},{"key":"R26-6-20210227","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0301-472X(99)00116-2","article-title":"The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.","volume":"27","author":"Hubinger","year":"1999","journal-title":"Exp Hematol"},{"key":"R27-6-20210227","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1535-6108(04)00084-4","article-title":"The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappa B activation in anaplastic large cell lymphoma.","volume":"5","author":"Horie","year":"2004","journal-title":"Cancer Cell"},{"key":"R28-6-20210227","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1200\/JCO.2005.01.2179","article-title":"Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkins lymphoma: results from Berlin-Frankfurt-Munster trial NHL-BFM 95.","volume":"23","author":"Seidemann","year":"2005","journal-title":"J Clin Oncol"},{"key":"R29-6-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/08880018909014580","article-title":"Glycosylated and total hemoglobin concentrations as prognostic factors in childhood acute lymphoblastic leukemia.","volume":"6","author":"Rautonen","year":"1989","journal-title":"Pediatr Hematol Oncol"},{"key":"R30-6-20210227","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1651-2227.2005.tb01914.x","article-title":"Interferon and tumour necrosis factor in relation to anemia and prognosis in childhood cancer.","volume":"94","author":"Ek","year":"2005","journal-title":"Acta Paediatr"},{"key":"R31-6-20210227","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.4049\/jimmunol.136.12.4487","article-title":"The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.","volume":"136","author":"Broxmeyer","year":"1986","journal-title":"J Immunol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e3182431e02","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T10:59:07Z","timestamp":1688295547000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201205000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e3182431e02","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}